Read + Share
Amedeo Smart
Independent Medical Education
Yacov N, Kafri P, Salem Y, Propheta-Meiran O, et al. MOSPD2 is a therapeutic target for the treatment of CNS inflammation. Clin Exp Immunol 2020;201:105-120.PMID: 32353176
Email
LinkedIn
Facebook
Twitter
Privacy Policy